Cathay Biotech Hits Day High with Strong 4.71% Intraday Surge

Cathay Biotech, Inc., a prominent player in the specialty chemicals sector, has experienced a notable increase of 4.71% on October 27, 2025. The stock reached an intraday high of CNY 50.85, reflecting a strong performance relative to the broader market, as the China Shanghai Composite index only rose by 0.71% on the same day.
Over the past week, Cathay Biotech has shown a 4.89% gain, outperforming the Shanghai Composite's 2.88% increase. However, its one-month performance indicates a decline of 3.71%, contrasting with the index's 2.51% rise. Year-to-date, the company has achieved a robust 28.27% increase, significantly surpassing the Shanghai Composite's 17.86%.

Financially, Cathay Biotech has reported positive results for the last four consecutive quarters, with a notable rise in profits by 35.4% over the past year. The company maintains a strong cash position of CNY 20,620.69 million and a low interest coverage ratio, indicating minimal interest costs. With a return on equity of 3.01% and a price-to-book ratio of 1.70, Cathay Biotech continues to demonstrate a solid market position within its industry.